Muneto Mogi
Novartis (United States)(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Glaucoma and retinal disorders, Retinal Development and Disorders, Complement system in diseases, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Small-molecule factor B inhibitor for the treatment of complement-mediated diseases(2019)211 cited
- → Small-molecule WNK inhibition regulates cardiovascular and renal function(2016)164 cited
- → Structure of neprilysin in complex with the active metabolite of sacubitril(2016)67 cited
- → Discovery of 4-((2 S ,4 S )-4-Ethoxy-1-((5-methoxy-7-methyl-1 H -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases(2020)59 cited
- → Efficient Route to 4a-Methyltetrahydrofluorenes: A Total Synthesis of (±)-Dichroanal B via Intramolecular Heck Reaction(2006)51 cited
- → Discovery and Characterization of Allosteric WNK Kinase Inhibitors(2016)44 cited
- → Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism(2017)36 cited
- → Asymmetric reduction of methoxy substituted β-tetralones using transfer hydrogenation(2004)25 cited
- → A small-molecule inhibitor of C5 complement protein(2019)20 cited
- → Pharmacology of novel intraocular pressure-lowering targets that enhance conventional outflow facility: Pitfalls, promises and what lies ahead?(2016)20 cited